In conclusion, this multicentre study revealed that AAT-A3F was especially increased in not only fibrosis, but also pathological inflammation and hepatocyte ballooning in patients with NAFLD, and AAT-A3F was considered useful for non-invasive diagnosis of early NASH. The gene discussed is SERPINA1; the disease is metabolic dysfunction-associated steatohepatitis.